Related Experiment Video
Updated: Aug 8, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates
Didier Ghisalberti1, Abdallah Mahamoud, Jacqueline Chevalier
1EA2197, IFR48, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France.
Abstract:
Efflux mechanisms protect bacterial cells by pumping out toxic compounds and actively contribute to bacterial multidrug resistance. Agents inhibiting efflux pumps are of interest for the control of multidrug-resistant bacterial infections. Herein we report the effects of new chloroquinoline derivatives that render resistant Enterobacter aerogenes isolates noticeably more susceptible to structurally unrelated antibiotics. In addition, some of these chloroquinolines increase the intracellular concentration of chloramphenicol. Some of the molecules tested in this work are able to inhibit the main efflux pump (AcrAB-TolC), which is involved in E. aerogenes antibiotic resistance.
Insights
New chloroquinoline derivatives can overcome bacterial multidrug resistance by inhibiting efflux pumps. These compounds make resistant bacteria more susceptible to antibiotics, offering potential new treatments for infections.
Area of Science:
- Microbiology
- Pharmacology
- Medicinal Chemistry
Background:
- Bacterial efflux pumps actively expel toxic compounds, contributing significantly to multidrug resistance.
- Targeting these efflux mechanisms is crucial for combating multidrug-resistant bacterial infections.
Purpose of the Study:
- To investigate the potential of novel chloroquinoline derivatives as inhibitors of bacterial efflux pumps.
- To evaluate the efficacy of these compounds in restoring antibiotic susceptibility in resistant bacterial strains.
Main Methods:
- Synthesis and characterization of new chloroquinoline derivatives.
- Testing the effect of derivatives on the susceptibility of multidrug-resistant Enterobacter aerogenes isolates to various antibiotics.
- Measuring intracellular antibiotic concentrations to confirm efflux pump inhibition.
Main Results:
- Several chloroquinoline derivatives demonstrated the ability to re-sensitize multidrug-resistant Enterobacter aerogenes to antibiotics.
- Some compounds were shown to increase intracellular chloramphenicol levels, indicating efflux pump inhibition.
- Specific molecules were identified as inhibitors of the AcrAB-TolC efflux pump, a key factor in E. aerogenes resistance.
Conclusions:
- Novel chloroquinoline derivatives show promise as agents to combat bacterial multidrug resistance.
- These compounds can restore antibiotic efficacy by inhibiting critical bacterial efflux pumps like AcrAB-TolC.
- Further development of these chloroquinolines could lead to new therapeutic strategies against resistant bacterial infections.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Anthelminthic Agents
